| CTRI Number |
CTRI/2026/01/102200 [Registered on: 27/01/2026] Trial Registered Prospectively |
| Last Modified On: |
27/01/2026 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Follow Up Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
study of analysing bleb morphology after trabeculectomy using anterior segment Optical Coherence Tomography |
|
Scientific Title of Study
|
analysing bleb morphology after trabeculectomy using anterior segment Optical Coherence Tomography |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DrSamra wahaj Fatima |
| Designation |
Glucoma Fellows |
| Affiliation |
Nethradhama Super Speciality Eye Hospital |
| Address |
256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA
Bangalore KARNATAKA 560070 India |
| Phone |
8374016816 |
| Fax |
|
| Email |
wjsam19@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DrSamra wahaj Fatima |
| Designation |
Glucoma Fellows |
| Affiliation |
Nethradhama Super Speciality Eye Hospital |
| Address |
256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA
KARNATAKA 560070 India |
| Phone |
8374016816 |
| Fax |
|
| Email |
wjsam19@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Asha MS |
| Designation |
Glaucoma Senior Consultant |
| Affiliation |
Nethradhama Super Speciality Eye Hospital |
| Address |
256/14, KANAKAPURA MAIN ROAD, JAYANAGAR 7TH BLOCK, BENGALURU, KARNATAKA
Bangalore KARNATAKA 560070 India |
| Phone |
9845373709 |
| Fax |
|
| Email |
drashamag@yahoo.co.uk |
|
|
Source of Monetary or Material Support
|
| 256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Ba |
|
|
Primary Sponsor
|
| Name |
Nethradhama Super Speciality Eye Hospital |
| Address |
256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore |
| Type of Sponsor |
Private hospital/clinic |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrSamra wahaj Fatima |
Nethradhama Super Speciality Eye Hospital |
256/14, Department of Phacorefractive surgery, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA Bangalore KARNATAKA Bangalore KARNATAKA
Bangalore
KARNATAKA Bangalore KARNATAKA |
83740 16816
wjsam19@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H258||Other age-related cataract, (2) ICD-10 Condition: H408||Other glaucoma, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
84.00 Year(s) |
| Gender |
Both |
| Details |
Post-trabeculectomy patients with primary glaucoma (open angle/angle closure)
underwent surgery when-uncontrolled on maximal medical treatment.
Baseline IOP was considered as an average of minimum two measurements, atleast two weeks apart. They were measured during different times of the day
|
|
| ExclusionCriteria |
| Details |
Patients with significant conjunctival scarring,ocular surface disease affecting imaging ,secondary glaucoma and congenital glaucoma.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Primary outcomes -determining the functionality of filtering bleb |
Follow up - day 1, 1 week, 6 weeks ,6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| determine success of trabeculectomy |
Follow up - day 1, 1 week, 6 weeks ,6 months |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
12/02/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
MethodologyThis prospective observational and descriptive study will be approved by the Institutional Ethics Committee of Nethradhama Eye Hospital and will adhere to the tenets of the Declaration of Helsinki. Verbal and written informed consent will be obtained from all patients participating in the study. Surgical ProcedureFollowing creation of a fornix based conjunctival flap a sponge soaked in Mitomycin C at a concentration of two hundred micrograms was applied under the conjunctiva for a duration of two minutes taking care that the Mitomycin C soaked sponge did not come in contact with the edge of the conjunctival flap. A partial thickness rectangular scleral flap was created followed by creation of a sclerostomy measuring two by two millimeters using scissors or Kelly punch. Closure of the scleral flap was performed using two side permanent sutures and one apical releasable ten zero nylon suture. The conjunctiva was closed using ten zero nylon sutures. Postoperatively antibiotic and steroid eye drops were administered in a tapering dose over a period of two months. Imaging and Evaluation of Filtering BlebAll blebs will be imaged using slit lamp photography under standardized illumination and magnification settings. All blebs will also be imaged using anterior segment optical coherence tomography using the Cirrus HD OCT five hundred system manufactured by Carl Zeiss Dublin California United States using a standardized imaging protocol. Optical coherence tomography is a high resolution tomographic and biomicroscopic imaging device designed for anterior segment imaging and measurement with an axial resolution of eighteen micrometers. The principle of imaging is based on low coherence interferometry using a thirteen hundred ten nanometer superluminescent light emitting diode. Similar to an ultrasound B scan the Cirrus OCT acquires multiple A scans and aligns them to construct two dimensional images. Patients will be instructed to look downward and the upper eyelid will be gently elevated to expose the bleb adequately while ensuring that no pressure is exerted on the globe or the bleb. Two scans namely radial and tangential will be obtained through the point of maximum bleb elevation. Assessment Parameters
Anterior segment optical coherence tomography images will be evaluated by a single trained observer who will be masked to the clinical data. Blebs will be assessed qualitatively for bleb height bleb wall thickness in millimeters bleb wall reflectivity categorized as low medium or high and bleb pattern classified as uniform or multiform. Scleral flap configuration measured in millimeters will also be evaluated. Additional features assessed include the scleral flap morphology and the route of aqueous flow beneath the scleral flap. |